SEARCH

SEARCH BY CITATION

References

  • Abifadel, M., Varret, M., Rabès, J. P., Allard, D., Ouguerram, K., Devillers, M., Cruaud, C., Benjannet, S., Wickham, L., Erlich, D., Derré, A., Villéger, L., Farnier, M., Beucler, I., Bruckert, E., Chambaz, J., Chanu, B., Lecerf, J. M., Luc, G., Moulin, P., Weissenbach, J., Prat, A., Krempf, M., Junien, C., Seidah, N. G., & Boileau, C. (2003) Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet 34, 154156.
  • Adzhubei, I. A., Schmidt, S., Peshkin, L., Ramensky, V. E., Gerasimova, A., Bork, P., Kondrashov, A. S., & Sunyaev, S. R. (2010) A method and server for predicting damaging missense mutations. Nat Methods 7, 248249.
  • Amsellem, S., Briffaut, D., Carrié, A., Rabès, J. P., Girardet, J.P., Fredenrich, A., Moulin, P., Krempf, M., Reznik, Y., Vialettes, B., de Gennes, J. L., Brukert, E., & Benlian, P. (2002) Intronic mutations outside of Alu-repeat-rich domains of the LDL receptor gene are a cause of familial hypercholesterolemia. Hum Genet 111, 501510.
  • Beglova, N. & S. C. Blacklow. (2005) The LDL receptor: How acid pulls the trigger. Trends Biochem Sci 30, 309317.
  • Brown, M. S. & J. L. Goldstein. (1986) A receptor-mediated pathway for cholesterol homeostasis. Science 232, 3447.
  • Cotton, R. G. & C. R. Scriver. (1998) Proof of “disease causing” mutation. Hum Mutat 12, 13.
  • Descamps, O. S., Tenoutasse, S., Stephenne, X., Gies, I., Beauloye, V., Lebrethon, M. C., De Beaufort, C., De Waele, K., Scheen, A., Rietzschel, E., Mangano, A., Panier, J. P., Ducobu, J., Langlois, M., Balligand, J. L., Legat, P., Blaton, V., Muls, E., Van Gaal, L., Sokal, E., Rooman, R., Carpentier, Y., De Backer, G., & Heller, F. R. (2011) Management of familial hypercholesterolemia in children and young adults: Consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization. Atherosclerosis 218, 272280.
  • Diakou, M., Miltiadous, G., Xenophontos, S. L., Manoli, P., Cariolou, M. A., & Elisaf, M. (2011) Spectrum of LDLR gene mutations, including a novel mutation causing familial hypercholesterolaemia, in North-western Greece. Eur J Int Med 22, e5559.
  • Djordjevic, J. T., Bieri, S., Smith, R., & Kroon, P. A. (1996) A deletion in the first cysteine-rich repeat of the low-density-lipoprotein receptor leads to the formation of multiple misfolded isomers. Eur J Biochem 239, 214219.
  • Dogan, R. I., Getoor, L., Wilbur, W. J., & Mount, S. M. (2007) SplicePort—An interactive splice-site analysis tool. Nucleic Acids Res 35, W285W291.
  • Dumić, M., Uroic, A. S., Francetić, I., Puretić, Z., Matisić, D., Kes, P., Mikecin, M., & Reiner, Z. (2007) Three-year-old boy—A homozygote for familiar hypercholesterolemia. Lijec Vjesn 129, 130133.
  • Dušková, L., Kopečková, L., Jansová, E., Tichý, L., Freiberger, T., Zapletalová, P., Soška, V., Ravčuková, B., & Fajkusová, L. (2011) An APEX-based genotyping microarray for the screening of 168 mutations associated with familial hypercholesterolemia. Atherosclerosis 216, 139145.
  • Eden, E. R., Patel, D. D., Sun, X. M., Burden, J. J., Themis, M., Edwards, M., Lee, P., Neuwirth, C., Naoumova, R. P., & Soutar, A. K. (2002) Restoration of LDL receptor function in cells from patients with autosomal recessive hypercholesterolemia by retroviral expression of ARH1. J Clin Invest 110, 16951702.
  • Garcia, C. K., Wilund, K., Arca, M., Zuliani, G., Fellin, R., Maioli, M., Calandra, S., Bertolini, S., Cossu, F., Grishin, N., Barnes, R., Cohen, J. C., & Hobbs, H. H. (2001) Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein. Science 292, 13941398.
  • Goldberg, A. C., Hopkins, P. N., Toth, P. P., Ballantyne, C. M., Rader, D. J., Robinson, J. G., Daniels, S. R., Gidding, S. S., de Ferranti, S. D., Ito, M. K., McGowan, M. P., Moriarty, P. M., Cromwell, W. C., Ross, J. L., & Ziajka, P. E. (2011) Familial hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients: Clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol 5, S1S8.
  • Gorr, S. U., Huang, X. F., Cowley, D. J., Kuliawat, R., & Arvan, P. (1999) Disruption of disulfide bonds exhibits differential effects on trafficking of regulated secretory proteins. Am J Physiol 277, C121C131.
  • Hebsgaard, S. M., Korning, P. G., Tolstrup, N., Engelbrecht, J., Rouzé, P., & Brunak, S. (1996) Splice site prediction in Arabidopsis thaliana pre-mRNA by combining local and global sequence information. Nucleic Acids Res 24, 34393452.
  • Humphries, S. E. (2012) Editor in Chief's Report for Atherosclerosis for 2011. Atherosclerosis 220, 12.
  • Humphries, S. E. & P. J. Talmud. (1995) Hyperlipidaemia associated with genetic variation in the apolipoprotein B gene. Curr Opin Lipidol 6, 215222.
  • Humphries, S. E., Whittall, R. A., Hubbart, C. S., Maplebeck, S., Cooper, J. A., Soutar, A. K., Naoumova, R., Thompson, G. R., Seed, M., Durrington, P. N., Miller, J. P., Betteridge, D. J., & Neil, H. A. (2006) Genetic causes of familial hypercholesterolaemia in patients in the UK: Relation to plasma lipid levels and coronary heart disease risk. J Med Genet 43, 943949.
  • Kumar, P., Henikoff, S., & Ng, P. C. (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4, 10731081.
  • Laurie, A. D., Scott, R. S., & George, P. M. (2004) Genetic screening of patients with familial hypercholesterolaemia (FH): A New Zealand perspective. Atheroscler Suppl 5, 1315.
  • Leigh, S. E., Foster, A. H., Whittall, R. A., Hubbart, C. S., & Humphries, S. E. (2008) Update and analysis of the University College London low density lipoprotein receptor familial hypercholesterolemia database. Ann Hum Genet 72, 485498.
  • Leren, T. P., Finborud, T. H., Manshaus, T. E., Ose, L., & Berge, K. E. (2008) Diagnosis of familial hypercholesterolemia in general practice using clinical diagnostic criteria or genetic testing as part of cascade genetic screening. Commun Genet 11, 2635.
  • Liguori, R., Argiriou, A., & Simone, V. D. (2003) A rapid method for detecting mutations of the human LDL receptor gene by complete cDNA sequencing. Mol Cell Probes 17, 1520.
  • Marks, D., Thorogood, M., Neil, H. A., & Humphries, S. E. (2003) A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia. Atherosclerosis 168, 114.
  • Mor-Cohen, R., Rosenberg, N., Peretz, H., Landau, M., Coller, B. S., Awidi, A., & Seligsohn, U. (2007) Disulfide bond disruption by a beta 3-Cys549Arg mutation in six Jordanian families with Glanzmann thrombasthenia causes diminished production of constitutively active alpha IIb beta 3. Thromb Haemost 98, 12571265.
  • Palacios, L., Grandoso, L., Cuevas, N., Olano-Martín, E., Martinez, A., Tejedor, D. & Stef, M. (2012) Molecular characterization of familial hypercholesterolemia in Spain. Atherosclerosis 221, 137142.
  • Reese, M. G., Eeckman, F. H., Kulp, D., & Haussler, D. (1997) Improved splice site detection in Genie. J Comput Biol 4, 311323.
  • Reiner, Z., Mihatov, S., Milicić, D., Bergovec, M., & Planinc, D. (2006) Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study). Eur J Cardiovasc Prev Rehabil 13, 646654.
  • Rukavina, A. S., Topić, R. Z., Ferencak, G., & Sucic, M. (2001) A novel missense mutation C127R (FH Zagreb) in the LDL-receptor gene. Clin Chem Lab Med 39, 505508.
  • Schwarz, J. M., Rödelsperger, C., Schuelke, M., & Seelow, D. (2010). MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods 7, 575576.
  • Simon Broome Register Group. (1991). Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee. BMJ 303, 893896.
  • Smart, M. C., Dedoussis, G., Louizou, E., Yannakoulia, M., Drenos, F., Papoutsakis, C., Maniatis, N., Humphries, S. E., & Talmud, P. J. (2010) APOE, CETP and LPL genes show strong association with lipid levels in Greek children. Nutr Metab Cardiovasc Dis 20, 2633.
  • Sözen, M. M., Whittall, R., Oner, C., Tokatli, A., Kalkanoğlu, H. S., Dursun, A., Coşkun, T., Oner, R., & Humphries, S. E. (2005) The molecular basis of familial hypercholesterolaemia in Turkish patients. Atherosclerosis 180, 6371.
  • Talmud, P., Lins, L., & Brasseur, R. (1996) Prediction of signal peptide functional properties: A study of the orientation and angle of insertion of yeast invertase mutants and human apolipoprotein B signal peptide variants. Protein Eng 9, 317321.
  • Taylor, A., Martin, B., Wang, D., Patel, K., Humphries, S. E., & Norbury, G. (2009) Multiplex ligation-dependent probe amplification analysis to screen for deletions and duplications of the LDLR gene in patients with familial hypercholesterolaemia. Clin Genet 76, 6975.
  • Timms, K. M., Wagner, S., Samuels, M. E., Forbey, K., Goldfine, H., Jammulapati, S., Skolnick, M. H., Hopkins, P. N., Hunt, S. C., & Shattuck, D. M. (2004) A mutation in PCSK9 causing autosomal-dominant hypercholesterolemia in a Utah pedigree. Hum Genet 114, 349353.
  • Traeger-Synodinos, J., Mavroidis, N., Kanavakis, E., Drogari, E., Humphries, S. E., Day, I. N., Kattamis, C., & Matsaniotis, N. (1998) Analysis of low density lipoprotein receptor gene mutations and microsatellite haplotypes in Greek FH heterozygous children: Six independent ancestors account for 60% of probands. Hum Genet 102, 343347.
  • Umans-Eckenhausen, M. A., Defesche, J. C., Sijbrands, E. J., Scheerder, R. L., & Kastelein, J. J. (2001). Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands. Lancet 357, 165168.
  • Usifo, E., Leigh, S. E., Whittall, R. A., Lench, N., Taylor, A., Yeats, C., Orengo, C. A., Martin, A. C., Celli, J., & Humphries, S. E. (2012) Low-density lipoprotein receptor gene familial hypercholesterolemia variant database: Update and pathological assessment. Ann Hum Genet 76, 387401.
  • Varret, M., Abifadel, M., Rabès, J. P., & Boileau, C. (2008) Genetic heterogeneity of autosomal dominant hypercholesterolemia. Clin Genet 73, 113.
  • Watts, G. F., Sullivan, D. R., Poplawski, N., van Bockxmeer, F., Hamilton-Craig, I., Clifton, P. M., O'Brien, R., Bishop, W., George, P., Barter, P. J., Bates, T., Burnett, J. R., Coakley, J., Davidson, P., Emery, J., Martin, A., Farid, W., Freeman, L., Geelhoed, E., Juniper, A., Kidd, A., Kostner, K., Krass, I., Livingston, M., Maxwell, S., O'Leary, P., Owaimrin, A., Redgrave, T. G., Reid, N., Southwell, L., Suthers, G., Tonkin, A., Towler, S., & Trent, R. (2011) Familial hypercholesterolaemia: A model of care for Australasia. Atheroscler Suppl 12, 221263.
  • Whittall, R. A., Scartezini, M., Li, K., Hubbart, C., Reiner, Z., Abraha, A., Neil, H. A., Dedoussis, G., & Humphries, S. E. (2010) Development of a high-resolution melting method for mutation detection in familial hypercholesterolaemia patients. Ann Clin Biochem 47, 4455.
  • Wierzbicki, A. S., Humphries, S.E., & Minhas, R. Guideline Development Group. (2008) Familial hypercholesterolaemia: Summary of NICE guidance. BMJ 337, a1095. doi: 10.1136/bmj.a1095